Client News

iOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer

CARBIOS and Zhink Group Enter Official Discussions for Long-Term Partnership to Build PET Biorecycling Industrial Capacities in China in View of First Licensing Agreement for 50k Tons per Year

Newron Pharmaceuticals Reports on its 2024 Investor Day in New York City

Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism

Medigene AG Reports Results of Annual General Meeting

InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)

Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems

Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors

Affluent Medical Achieves the Clinical Objective of the Dry Pilot Study in the First Two Patients with the Artus Artificial Urinary Sphincter

Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City